Article 223-16 du Règlement général de l’Autorité des marchés financiers Regulatory News: Integragen (Paris:ALINT): ...
Strong growth in revenue (+8%) linked to the development of partnerships in very high-speed sequencing with Institut Pasteur and Gustave...
Regulatory News: Au titre du contrat de liquidité confié par la société IntegraGen S.A (Paris:ALINT) à Oddo Corporate Finance, à la date...
Financials Sales of € 2.8 million, a 10% increase vs. H1 2015 Operational result +14% Most significant scientific &...
Data presented concludes that miR-31-3p expression is predictive of anti-EGFR therapy effect on objective response, depth of response, and...
Chiffre d’affaires de 2,9 M€, en progression de plus de 10% par rapport au premier semestre 2015 Importantes avancées scientifiques et...
Regulatory News: The Greater Paris University Hospitals, AP-HP and the molecular genomics company IntegraGen (Paris:ALINT) announced...
The Greater Paris University Hospitals, AP-HP and the molecular genomics company IntegraGen announced today the signature of an agreement to...
Data reports miR-31-3p expression predicts improved survival and response with anti-EGFR therapy compared to anti-VEGF therapy in patients...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.